Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, May 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Negligent pharmacology

OAKLAND, Ca. — A federal judge in California allowed negligence claims to proceed against the makers of the anti-inflammatory drug montelukast, brand-name Singulair, because it can cause neuropsychiatric injuries, as it crosses the blood-brain barrier.

Read the ruling here.

Categories / Briefs, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.